Edwards Lifesciences Fem-Flex Femoral Arterial Cannula with Duraflo Coating, DIITFA02225, Sterile, RX only For Single Use Only, Product Usage: Edwards Lifesciences femoral access cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Femoral access cannulae may be used in pediatric populations or adult populations based on flow rate requirements and individual patient anatomy. Please consult labeling to determine pressure drop related to flow rates. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin coated blood path is desired.
Publicado el 13 de noviembre de 2013 · Inicio del retiro: 26 de agosto de 2013
Resumen
FDA registra el retiro Z-0134-2014 de dispositivos médicos de Clase II, publicado el 13 de noviembre de 2013 e iniciado el 26 de agosto de 2013. Empresa responsable: Edwards Lifesciences, LLC; Estado: Finalizado; Cantidad reportada: 80 units; Lote: Lot number 59388992 expiry 1/1/16. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Edwards Lifesciences is recalling two lots of Duraflo Cannulas due to reported complaints involving cracks in the t-connector of the devices which were confirmed during product evaluation.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Edwards Lifesciences, LLC
- Distribuidor
- Nationwide Distribution.
- Lote
- Lot number 59388992 expiry 1/1/16
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAGeneric Name: Edwards Commander M Delivery System Generic Name: Edwards Commander M Delivery System11 de noviembre de 2026
- FDAEdwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO20 de mayo de 2026
- FDABrand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016AS Software16 de julio de 2025
- FDABrand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI1616 de julio de 2025
- FDAThe EkoSonic Endovascular System employs high frequency (2-2.5 MHz), low power (0.585 watt average power per13 de noviembre de 2013
- FDAEdwards Lifesciences Dispersion Aortic Perfusion Cannula with Duraflo Coating, Sterile, RX only For Single Use13 de noviembre de 2013
Preguntas sobre este retiro
¿Edwards Lifesciences Fem-Flex Femoral Arterial Cannula with Duraflo Coating, DIITFA02225, Sterile, RX only For Single Use Only, Product Usage: Edwards Lifesciences femoral access cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (< 6 hours) cardiopulmonary bypass. Vessel access (venous or arterial) is left to the discretion of the physician. Femoral access cannulae may be used in pediatric populations or adult populations based on flow rate requirements and individual patient anatomy. Please consult labeling to determine pressure drop related to flow rates. Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin coated blood path is desired. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0134-2014 el 13 de noviembre de 2013. Peligro reportado: Edwards Lifesciences is recalling two lots of Duraflo Cannulas due to reported complaints involving cracks in the t-connector of the devices which were confirmed during product evaluation.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter